Stay updated with breaking news from Irit Rappley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.
Roche and its Genentech subsidiary have committed up to $12 billion to Recursion in return for using its Recursion Operating System (OS) to advance therapies in 40 programs that include “key areas” of neuroscience and an undisclosed oncology indication.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
BioSpace Movers & Shakers, Dec. 3 - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery,...